摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-tert-butyl-4-chloro-2-methyl-2H-pyrazole-3-carboxylic acid [5-bromo-3-(4-methoxy-benzylamino)-pyrazin-2-yl]-amide | 1332875-30-5

中文名称
——
中文别名
——
英文名称
5-tert-butyl-4-chloro-2-methyl-2H-pyrazole-3-carboxylic acid [5-bromo-3-(4-methoxy-benzylamino)-pyrazin-2-yl]-amide
英文别名
N-[5-bromo-3-[(4-methoxyphenyl)methylamino]pyrazin-2-yl]-5-tert-butyl-4-chloro-2-methylpyrazole-3-carboxamide
5-tert-butyl-4-chloro-2-methyl-2H-pyrazole-3-carboxylic acid [5-bromo-3-(4-methoxy-benzylamino)-pyrazin-2-yl]-amide化学式
CAS
1332875-30-5
化学式
C21H24BrClN6O2
mdl
——
分子量
507.818
InChiKey
DHDQDSOGFYUXRS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    94
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
    申请人:Player Mark R.
    公开号:US08680098B2
    公开(公告)日:2014-03-25
    The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    本发明涉及替代的氮杂双环咪唑衍生物、包含它们的制药组合物以及它们在治疗受TRP M8调节的疾病和症状中的应用,包括但不限于炎症性疼痛、炎症性过敏症、炎症性过敏症状、神经病性疼痛、神经病性冷痛觉、炎症性体表过敏症、炎症性内脏过敏症、受寒冷加重的心血管疾病和受寒冷加重的肺部疾病。
  • Substituted AZA-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
    申请人:Janssen Pharmaceutica, NV
    公开号:US09023846B2
    公开(公告)日:2015-05-05
    The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    本发明涉及取代的氮杂双环咪唑衍生物,包含它们的制药组合物以及它们在治疗TRP M8调节的疾病和病症中的应用,例如炎症性疼痛、炎症性过敏症、炎症性过敏性症状、神经病性疼痛、神经病性冷痛觉过敏、炎症性体表过敏症、炎症性脏器过敏症、寒冷加重的心血管疾病和寒冷加重的肺部疾病。
  • [EN] SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS<br/>[FR] DÉRIVÉS D'IMIDAZOLE AZA-BICYCLIQUES SUBSTITUÉS UTILES COMME MODULATEURS DES RÉCEPTEURS TRPM8
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2011109587A1
    公开(公告)日:2011-09-09
    The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
  • SUBSTITUTED AZA-BICYCLIC IMIDAZOLE DERIVATIVES USEFUL AS TRPM8 RECEPTOR MODULATORS
    申请人:PLAYER Mark R.
    公开号:US20110218197A1
    公开(公告)日:2011-09-08
    The present invention is directed to substituted aza-bicyclic imidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by TRP M8, including for example, inflammatory pain, inflammatory hyperalgesia, inflammatory hypersensitivity condition, neuropathic pain, neuropathic cold allodynia, inflammatory somatic hyperalgesia, inflammatory visceral hyperalgesia, cardiovascular disease aggravated by cold and pulmonary disease aggravated by cold.
    本发明涉及替代的氮杂双环咪唑衍生物,含有它们的药物组合物以及它们在治疗由TRP M8调节的疾病和症状中的用途,包括但不限于炎症性疼痛、炎症性过敏症、炎症性过敏性疾病、神经病性疼痛、神经性寒冷痛觉过敏、炎症性体感过敏、炎症性内脏过敏、受寒加重的心血管疾病和受寒加重的肺部疾病。
查看更多